Skip to content

AI-HEALS Intervention Based on Human-AI Behavior Integration Theory (HABIT) for Improving Medication Adherence in Patients With Cancer Pain: A Pilot Trial

AI-HEALS Intervention Based on Human-AI Behavior Integration Theory (HABIT) for Improving Medication Adherence in Patients With Cancer Pain: A Pilot Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600128059
Enrollment
Unknown
Registered
2026-07-13
Start date
2026-07-20
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer pain

Interventions

Intervention Group:artificial intelligence-based interventions
control group:Standard hospital care services

Sponsors

Pujiang County Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age =18 years. 2.Clinically diagnosed as malignant tumor. 3.Associated with moderate to severe pain (Numerical Rating Scale [NRS] =4 points; 4.Currently receiving standardized pharmacological treatment for cancer pain. 5.Possesses clear awareness, owns a smartphone, is proficient in the basic functions of WeChat, and can operate AI-HEALS independently or under guidance. 6.The survival time assessed by a physician exceeds 6 months. 7.Voluntarily participate and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Severe complications such as hepatic and renal failure. 2.Presence of severe mental disorders or cognitive impairments. 3.Concurrent participation in other intervention-based clinical studies. 4.Unable or unwilling to use the AI-HEALS research system. 5.Refusers: Individuals who still refuse to participate in the study after explanation, or decline to sign the informed consent form. 6.The expected survival period is assessed by the attending physician to be less than 6 months. 7.Experience severe adverse reactions caused by the use of psychotropic or narcotic drugs (e.g., severe respiratory depression, severe hypotension, etc.).

Design outcomes

Primary

MeasureTime frame
Supplemental administration and medication adherence;

Secondary

MeasureTime frame
Quality of life for patients with cancer pain;Pain Self-Efficacy;Impact of pain on function;

Countries

China

Contacts

Public ContactZhao Qiqi

Pujiang County Traditional Chinese Medicine Hospital

385252800@qq.com+86 579 8413 3189

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026